Sort By:

  Add to Compare   Add to Compare   Add to Compare   Add to Compare
Vardenafil composed Filitra pills helps in dealing with repeated penile failure called as Erectile Dysfunction. This solution is composed in various strengths and consumption form that helps in boosting up sexual capabilities. The solution decreases arterial failures and boosts up penile capabilities in men. Medicine is also available in various strengths and pills form for convenience of oral consumption and relieving impotence in minutes.
Manufacturer: Fortune HealthCare Pvt. Ltd.
About Vardenafil in Filitra Pills:
Drug Vardenafil in the medicine Filitra is chemically denoted as C23H32N6O4S. Component has a systematic name as 4-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-9-methyl-7-propyl-3,5,6,8-tetrazabicyclo [4.3.0]nona-3,7,9-trien-2-one and molecular weight 488.60298 g/mol.
Available Dosage & Medicine Format of Filitra:
Filitra medicine is available in various strengths like 10mg, 20mg and 40mg that are available in 2 forms including conventional tablet and sublingual tablet for oral consumption.
Action Mechanism and Effectiveness of Vardenafil:
Vardenafil in Filitra is a known phosphodiesterase type5 (PDE5) inhibitor. The main active component in the medicine works sensationally by enhancing blood flow into the penile while being sexually aroused. Appropriate flow of blood loosens arterial blockage that helps men to achieve and sustaining a stiffer penile.
Maximum 12 hours effectiveness can be observed with consumption of the medicine. However, effectiveness depends on the strength and consumption pattern followed.
Side Effects:
Some common side effects with Filitra consumption include warmth or redness in face, neck, or chest, runny or stuffy nose, headaches, dizziness, upset stomach, and back pain. Such mild effects are nothing to worry about as they might vanish soon. Excessive consumption of medicine or allergic reactions might need medical assistance.

Live Chat
Send Offline Message
Logos and trademarks remain the property of the corresponding companies. © 2024 >
Logos and trademarks remain the property of the corresponding companies. © 2024